Connaissances et croyances des patients en matière d’hépatites chroniques B et C en République du Bénin

Kodjoh, N.; Latoundji, S.; Kpossou, Aboudou Raïmi; Alassan, Khadidjatou Saké; Vignon, Rodolph Koffi; Houinato, Dismand

doi:10.1007/s12157-014-0571-y

Cited by 4 publications

(6 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most common risk factor found in this study was scarification (84.93%). The same finding was made by Kodjoh et al [10] (52.6%) in Cotonou, Benin in 2013; but also by Kowo et al [8] (71.3%) in Douala and Yaoundé in Cameroon in 2015. This result can be explained by the fact that this practice is particularly widespread in sub-Saharan Africa in general and in the northern regions of Benin in particular.…”

Section: Discussionsupporting

confidence: 79%

“…A male predominance was noted with a sex ratio of 1.2 in the study population. The same observation was made by Kodjoh et al [10] in Cotonou, Benin in 2014 with a sex ratio of 3.6 and by Sombié et al [11] in Burkina Faso in 2011 with a sex ratio of 1.9.…”

Section: Discussionsupporting

confidence: 75%

“…HCV-HIV co-infection was found in 1 patient (1.4%). This rate of co-infection is relatively lower than those reported by Kodjoh et al [10]. in Cotonou, Benin in 2012 (3%) and Kowo et al [8] in Douala and Yaoundé, Cameroon, in 2015 (2.8%).…”

Section: Discussioncontrasting

confidence: 51%

See 2 more Smart Citations

Hepatitis C Virus Infection: Epidemiological, Diagnostic and Therapeutic Aspects at the Departmental and Teaching Hospital of Borgou-Alibori

CA,

et al. 2023

AustinJInfectDis

View full text Add to dashboard Cite

Introduction: Hepatitis C Virus (HCV) infection is a global public health problem. The epidemiology of this condition in Parakou is still poorly understood. The aim of this study was to investigate the epidemiological, diagnostic and therapeutic aspects of hepatitis C virus infection in the internal medicine department of the Departmental and Teaching Hospital of Borgou-Alibori (DTH-B/A), Parakou. Patients and Methods: This was a descriptive cross-sectional study with retrospective data collection. It concerned patients received in hepato-gastroenterology consultation from 1st January, 2017 to 30 June, 2021. Patients who had undergone a minimal pre-therapeutic workup, which included testing for hepatitis C virus antibodies (anti-HCV Ac) and quantification of viral RNA by PCR, were included. The data were collected from each patient’s medical record and transcribed on a pre-established collection form. Analysis was performed using Epi Info software version 7.2. Results: During the study period, 2786 patients were seen in hepato-gastroenterology consultations. Among them, 142 patients (5.1%) were HCV-positive. Of these seropositive patients, 73 (51.4%) met the inclusion criteria and were selected for the present study. The mean age was 45.5±14.7 years. Thirty-nine (53.4%) were male, for a sex ratio of 1.2. Forty-seven (64.4%) had progressive HCV infection with detectable RNA, including 3 (6.4%) at the stage of liver cirrhosis. Treatment was indicated in these 47 patients (64.4%) and was effective in 35 (74.5%). In all these patients, the HCV RNA test at the control PCR at least three months after the end of treatment was negative (undetectable RNA), representing a sustained virological response of 100%. Conclusion: At DTH-B/A, HCV infection most often affects young adult males. Viremic forms are in the majority. Treatment with direct-acting antivirals remains highly effective.

show abstract

Section: Discussionsupporting

confidence: 79%

Section: Discussionsupporting

confidence: 75%

See 1 more Smart Citation

Hepatitis C Virus Infection: Epidemiological, Diagnostic and Therapeutic Aspects at the Departmental and Teaching Hospital of Borgou-Alibori

CA,

et al. 2023

AustinJInfectDis

View full text Add to dashboard Cite

show abstract

“…Multiple use of contaminating materials and sexual risk behaviors were the most found risk factors in the patients' story. Kodjoh [22] made the same finding in his study.…”

Section: Discussionsupporting

confidence: 74%

Hepatitis B Surface Antigen Serum Level Is Correlated with Fibrosis Severity in Treatment-Naïve, Chronic Hepatitis B Patients in Côte d’Ivoire (West Africa)?

Bathaix¹,

Soro²,

Bangoura³

et al. 2015

OJGas

View full text Add to dashboard Cite

HBsAg serum level (quantification) may be useful for managing hepatitis B virus (HBV) infection patients. However few studies especially in Africa have evaluated the association between HBsAg serum level and liver fibrosis severity. The objective of this study was to estimate the correlation between HBsAg serum level and liver fibrosis severity with treatment naïve chronic hepatitis B patients in Côte d'Ivoire. Methodology: It is a prospective study covering from February 1 st , 2014 to April 30 st , 2015 at Centre Hospitalier et Universitaire de Yopougon and a private medical office in Abidjan, Côte d'Ivoire. Inclusion criteria for patients were: HBsAg positive, known HBeAg status, serum HBsAg levels, serum HBV DNA levels, complex serum markers and absence of HCV, HDV, or HIV co-infection, drinking more than 30 g/day for men and 20 g/day in women over 10 years, metabolic disease and/or hepatic overload. Pearson's Chi-square test (r2), Anova, Spearman, T-Student, Pearson's (r) correlations and Mann Withney's Test were carried out as appropriate. A p value < 0.05 was taken as significant. Results: We recruited, 105 patients (77 men) of whom the medium age was 39.01 ± 9.72 years. Predominant hepatitis B viral genotype was E (93%). Less than 10% patients had an inactive HBV in HBeAg-negative. Patients had an average high HBsAg serum level (mean 12111.2 ± 10617.4 IU/ml) as well as the one viral load (mean 4.4 e7 ± 7.5 e7). Serum ALAT levels averaged at the upper limit of normal value. The average liver fibrosis score was 0.34 ± 0.22

show abstract

“…The media has played a guiding role for the use of a doctor in a quarter of cases because the information-education-communication programs (IEC) on hepatitis in general public places and populations risk are poorly developed, not funded by the state. The result is subinformation of infected persons about their disease concerning the detection, the possibilities of prevention, the care and treatment [6]. That's why four out of ten patients had consulted someone on the recommendation of a relative.…”

Section: Discussionmentioning

confidence: 99%

Therapeutic Itineraries of Patients with Chronic Hepatitis B and C in Benin: The Wanderings in Search of Care towards the Therapeutic Impasse

Kodjoh

Sbi

et al. 2017

GHOA

View full text Add to dashboard Cite

Introduction: Viral hepatitis B and C are endemic in the Republic of Benin. However, no national strategy is in place to support patients and to control these diseases. This study aims to trace the therapeutic itineraries of patients seeking care and to assess the cost of treatment steps. Patients and Methods:This is a descriptive and analytical prospective, crosssectional study, conducted from January to June 2010 in the Department of Gastroenterology and Hepatology of the National and University Hospital of Cotonou. Information on the therapeutic management was collected from patients with hepatitis B or C in direct interview. Results:One hundred and two patients were included. For the first visit, 73.5% of patients were using modern medicine against 20.6% for traditional medicine. In contrast, 58% of those who consulted a second line and more made use of traditional healers. The average number of practitioners consulted by each patient was 2.72 ± 1.84 with a maximum of seven practitioners consulted. The alleged curative treatments offered were not antiviral. The average cost of these treatments was illusory 112,000 FCFA while the minimum wage is only 31,600 FCFA in Benin. Conclusion:This study highlights the shortcomings of the national health system response to the issue of hepatitis, and the need to make the fight against these endemic diseases a public health priority.

show abstract

Connaissances et croyances des patients en matière d’hépatites chroniques B et C en République du Bénin

Cited by 4 publications

References 7 publications

Hepatitis C Virus Infection: Epidemiological, Diagnostic and Therapeutic Aspects at the Departmental and Teaching Hospital of Borgou-Alibori

Hepatitis C Virus Infection: Epidemiological, Diagnostic and Therapeutic Aspects at the Departmental and Teaching Hospital of Borgou-Alibori

Hepatitis B Surface Antigen Serum Level Is Correlated with Fibrosis Severity in Treatment-Naïve, Chronic Hepatitis B Patients in Côte d’Ivoire (West Africa)?

Therapeutic Itineraries of Patients with Chronic Hepatitis B and C in Benin: The Wanderings in Search of Care towards the Therapeutic Impasse

Contact Info

Product

Resources

About

Connaissances et croyances des patients en matière d’hépatites chroniques B et C en République du Bénin

Cited by 4 publications

References 7 publications

Hepatitis C Virus Infection: Epidemiological, Diagnostic and Therapeutic Aspects at the Departmental and Teaching Hospital of Borgou-Alibori

Hepatitis C Virus Infection: Epidemiological, Diagnostic and Therapeutic Aspects at the Departmental and Teaching Hospital of Borgou-Alibori

Hepatitis B Surface Antigen Serum Level Is Correlated with Fibrosis Severity in Treatment-Na&#239;ve, Chronic Hepatitis B Patients in C&#244;te d’Ivoire (West Africa)?

Therapeutic Itineraries of Patients with Chronic Hepatitis B and C in Benin: The Wanderings in Search of Care towards the Therapeutic Impasse

Contact Info

Product

Resources

About

Hepatitis B Surface Antigen Serum Level Is Correlated with Fibrosis Severity in Treatment-Naïve, Chronic Hepatitis B Patients in Côte d’Ivoire (West Africa)?